ScriptCheckSA - Real Time Prescription Monitoring in South Australia

The RTPM Project Team is seeking Expressions of Interest (EOI) from AHPRA registered prescribers and pharmacists to participate in the small-scale testing of ScriptCheckSA (PDF 170KB).

If you would like to register your interest in participating in the small-scale testing programme, email: RTPM Project Team - with your name, AHPRA number and contact details by 12pm on Friday 11 September 2020.

ScriptCheckSA is the name of South Australia’s real time prescription monitoring computer system. ScriptCheckSA provides prescribers and pharmacists with real-time information about a patient’s use of monitored medicines when they are considering prescribing or dispensing these medicines, to ensure safer clinical decisions.

What is Real Time Prescription Monitoring?

Real Time Prescription Monitoring (RTPM) uses a computer system to provide prescribers (e.g. doctors) and pharmacists with information about a patient’s use of monitored medicines when they are considering prescribing or dispensing these medicines.

ScriptCheckSA is the name of South Australia’s RTPM computer system.

Why is ScriptCheckSA being implemented in South Australia?

Prescription drug dependence, misuse and diversion are increasing concerns both in Australia and internationally – with associated overdose and accidental death continuing to rise in Australia.

Controlled drugs include pain medications such as oxycodone, morphine and fentanyl, some medications used to manage anxiety, narcolepsy or ADHD including dexamfetamine, methylphenidate and alprazolam.

A RTPM system such as ScriptCheckSA can help reduce misuse and ensure that patients who genuinely need these medicines can still get them.

In 2018, the State Government committed $7.5 million to implement a RTPM system in South Australia and it is anticipated that ScriptCheckSA will be available for prescribers and pharmacists to use in early 2021.

What are the aims of ScriptCheckSA?

ScriptCheckSA will not stop a doctor or pharmacist from prescribing or dispensing a monitored medicine; this decision will remain at the professional discretion of the health practitioner.

ScriptCheckSA aims to help prescribers and pharmacists by:

  • identifying patients who are at risk of harm due to dependence or misuse of controlled drugs
  • identifying patients who may be diverting these medicines
  • minimising ‘doctor shopping‘ (when a person visits multiple prescribers for prescriptions of a controlled drug).

Alerting prescribers and pharmacists in real-time to information about a person’s access to potentially harmful prescription drugs will allow them to make safer clinical decisions before they prescribe or dispense a controlled drug and potentially reduce the risk of death caused by preventable overdose.

ScriptCheckSA will also help SA Health regulators (Drugs of Dependence Unit) identify prescribers who are not complying with the Controlled Substances laws. Early identification of high-risk prescribing behaviour can help to reduce the risk of harm to patients from controlled drugs.

How will ScriptCheckSA work?

There are two parts:

  1. The National Data Exchange (NDE) that captures information from state and territory regulatory systems, prescribing and dispensing software and a range of external data sources.
  2. SA Regulatory Portal that manages legal authorities to prescribe drugs of dependence and allows the Drugs of Dependence Unit (DDU) to perform the regulation and monitoring responsibilities of the Health Minister under the Controlled Substances laws.

ScriptCheckSA will be integrated into most existing prescribing and dispensing software and will produce real-time alerts and notifications for prescribers, pharmacists and regulators.
Prescribers and pharmacists will receive a notification if there is information in ScriptCheckSA that should be considered before a prescription for a monitored medicine is written or dispensed.

For prescribers and pharmacists that don’t use software with RTPM capability, they will be able to access patient information through an Online Health Practitioner Portal or by contacting the DDU by phone (1300 652 584) or email

Who will be able to access a patient’s record in ScriptCheckSA?

Only doctors and pharmacists involved in the patient’s care, including those working in hospitals will be able to view information in ScriptCheckSA.

Penalties will apply to any person who is found to be inappropriately accessing, sharing or using information obtained from ScriptCheckSA.

Impact of ScriptCheckSA on patients

ScriptCheckSA will not stop a patient from obtaining their regular medicines where their doctor has identified a legitimate clinical need.

Impact of ScriptCheckSA on prescribers and pharmacists

Integration of ScriptCheckSA into prescribing and dispensing software means that existing prescribing and dispensing workflows will remain unchanged. Prescribers and pharmacists will be able to access information through a direct link in the ScriptCheckSA notification.

ScriptCheckSA will not stop doctors or pharmacists from prescribing or dispensing monitored medicines. Whether it is clinically appropriate to prescribe or dispense a medication remains the professional responsibility of the treating prescriber or pharmacist.

Education and training about how to access and use ScriptCheckSA will be made available for prescribers and pharmacists in the latter part of 2020.

Which medicines will be monitored through ScriptCheckSA?

ScriptCheckSA will monitor all Schedule 8 medicines (controlled drugs, drugs of dependence) and some high-risk Schedule 4 medicines.

The list of monitored medicines will be finalised after public consultation occurs in mid-2020.


Real Time Prescription Monitoring | ScriptCheckSA
Drugs of Dependence Unit